Résultats de la recherche - Fred Reid
- Résultat(s) 1 - 3 résultats de 3
-
1
Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease par Muhammad Waqas Sadiq, Hongtao Yu, Magnus Åstrand, Ian C. Scott, Adam Williams, Lisa Hewitt, N. E. White, Helen Killick, Monica L. Gavala, E. Suzanne Cohen, Fred Reid, Chris Kell, Hitesh Pandya, Eulalia Jiménez
Publié 2024Artigo -
2
A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4 par Dave Singh, Patricia Guller, Fred Reid, Sarah Doffman, Ulla Seppälä, Ioannis Psallidas, Rachel Moate, Rebecca Smith, Joanna Kiraga, Eulalia Jiménez, Dennis E. Brooks, Aoife Kelly, Lars H. Nordenmark, Muhammad Waqas Sadiq, Luis Mateos Caballero, Chris Kell, Maria G. Belvisi, Hitesh Pandya
Publié 2025Artigo -
3
A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease par Fred Reid, Dave Singh, Muna Albayaty, Rachel Moate, Eulalia Jiménez, Muhammad Waqas Sadiq, David Howe, Monica L. Gavala, Helen Killick, Adam Williams, Surekha Krishnan, A. Godwood, Animesh Shukla, Lisa Hewitt, Alejhandra Lei, Chris Kell, Hitesh Pandya, Paul J. Newcombe, N. E. White, Ian C. Scott, E. Suzanne Cohen
Publié 2023Artigo
Outils de recherche:
Sujets similaires
Internal medicine
Medicine
Antibody
Chemistry
Gastroenterology
Immunology
Pulmonary disease
Archaeology
Bioavailability
Biochemistry
Biomarker
COPD
Confidence interval
Disease
Dosing
Environmental health
Frontier
History
Monoclonal antibody
NONMEM
Organic chemistry
Pharmacokinetics
Pharmacology
Phase (matter)
Population
Randomized controlled trial
Volume of distribution